J Physiol Volume 512, Number 3, 779-791, November 1, 1998
The Journal of Physiology (1998), 512.3, pp. 779-791
© Copyright 1998 The Physiological Society
Overexpression of nerve growth factor in the heart alters ion channel activity and
-adrenergic signalling in an adult transgenic mouse
B. M. Heath, J. Xia, E. Dong, R. H. An, A. Brooks, C.-S. Liang, H. J. Federoff and R. S. Kass
College of Physicians and Surgeons of Columbia University, Department of Pharmacology, 630 West 168th Street, New York, NY 10032, USA
Received 22 April 1998; accepted after revision 17 July 1998.
 |
ABSTRACT |
- The electrophysiological and pharmacological properties of cardiac myocytes from the hearts of adult transgenic mice engineered to overexpress nerve growth factor (NGF) in the heart were studied.
- There was a 12 % increase in the ventricular myocyte capacitance in NGF myocytes consistent with cardiac hypertrophy, and action potential duration at 90 % repolarization (APD90) was prolonged by 142 % compared with wild-type (WT) myocytes. This was due, at least in part, to a decrease in the density of two K+ currents, Ito and IK(ur), which were significantly reduced in NGF mice with no change in their electrophysiological characteristics. We found no change in the current density or electrophysiological properties of the L-type Ca2+ current.
- The effect on Ito and IK(ur) of TEA and 4-aminopyridine (4-AP) was not different in cells isolated from WT and NGF mice. The prolongation of APD observed in NGF cells was mimicked in WT cells by exposure to 1 mM 4-AP, which partially blocked Ito, completely blocked IK(ur) and increased APD90 by 157 %.
- The isoprenaline-induced increase in ICa was significantly smaller in NGF myocytes than in WT myocytes. This was not due to a decrease in
-adrenergic receptor (
-AR) density, as this was increased in NGF tissue by 55 %. Analysis of
-AR subtypes showed that this increase was entirely due to an increase in
2-AR density with no change in
1-ARs.
- The response of the
-AR-coupled adenylyl cyclase system to isoprenaline, Gpp(NH)p and forskolin was studied by measuring cAMP production. In NGF tissue, isoprenaline elicited a significantly smaller response than in WT myoyctes and this was not due to reduced adenylyl cyclase activity as the responses of NGF tissue to guanylylimidodiphosphate (Gpp(NH)p) and forskolin were unaffected.
- In conclusion, the overexpression of NGF in the mouse heart resulted in a decrease in the current density of two K+ channels, which contributed to the prolongation of the cardiac action potential. Despite an increase in
2-AR density in the hearts of the NGF mice, the response to isoprenaline was diminished, and this was due to an uncoupling of the
-ARs from the intracellular signalling cascade. These potentially pathological changes may be involved in the occurrence of ventricular arrhythmias in cardiac hypertrophy and failure, and this mouse provides a novel model in which to study such changes.
 |
INTRODUCTION |
Congestive heart failure is a clinical syndrome characterized by sympathetic activation with elevated plasma noradrenaline and increased cardiac release of noradrenaline. This results in positive inotropic and lusitropic effects which are potentially beneficial adaptations to acute circulatory stress. During the progression of heart failure, a great many changes take place in the myocardium including hypertrophy. However, heart failure is not just a mechanical problem that leads to progressive pump dysfunction, it is also associated with alterations in the electrical activity of the heart, and some of these changes can lead to the generation of ventricular arrhythmias, which may result in sudden death (Kottkamp et al. 1994). In particular, abnormal sympathetic activity has been implicated in the development of lethal arrhythmias (Schwartz et al. 1985), and elevated plasma levels of catecholamines have been directly related to increased mortality in chronic heart failure (Francis et al. 1993).
Recently, a transgenic mouse has been developed that selectively overexpresses nerve growth factor (NGF) in the heart by the use of the cardiac-specific promoter
-myosin heavy chain (MHC; Hassankhani et al. 1995). NGF is a target organ-derived neurotrophin which supports the survival of sympathetic and neural crest-derived sensory neurons during embryonic development. In the adult, NGF maintains the neurotransmitter phenotype of mature noradrenergic sympathetic neurons and some cholinergic neurons of the CNS. Overexpression of NGF in the mouse heart results in sympathetic hyperinnervation, cardiomegaly and elevated levels of catecholamines (Hassankhani et al. 1995). In later life, these transgenic mice develop severe heart disease and cardiac failure, emphasizing the importance of neural- cardiac interactions in cardiac development.
This transgenic mouse provides a novel model of heart failure in which to study at the single myocyte level the consequences of selective cardiac sympathetic hyperactivity. Herein, we study the electrophysiological and pharmacological properties of cardiac myocytes from the hearts of adult transgenic mice to characterize the mechanisms underlying the dysfunction that may contribute to some of the electrical and functional abnormalities reported to occur in heart failure (Hart, 1994).
 |
METHODS |
MHC NGF transgenic animals
The studies were approved by the University of Rochester Committee on Animal Resources and conformed to the guiding principles approved by the Council of the American Physiological Society and the National Institutes of Health Guide on the humane care and use of laboratory animals. The MHC NGF transgenic mice were maintained in a DBA2J background. Matings were between transgenic and wild-type (WT) mice, and PCR genotyping of litters was performed as described previously (Hassankhani et al. 1995). Male mice were studied at 4-8 weeks of age. Transgenic mice, littermate non-transgenic controls and non-littermate DBA2J controls were studied. For pharmacological studies, animal weights were recorded prior to cervical dislocation. Ventricular muscle was stored in liquid nitrogen for the radioligand and adenylyl cyclase experiments.
Isolation of ventricular myocytes
Ventricular myocytes were isolated daily from the hearts of transgenic and WT mice using the following procedure. Mice were anaesthetized with ketamine and xylazine (0·1 ml (30 g body weight)-1, 15·2 mg ml-1 of each) and were heparinized (200 U) before the heart was excised into ice-cold solution (solution 1) consisting of minimum essential medium (Joklik-modified, Gibco) to which was added 5·56 mM glucose and 23·8 mM NaHCO3 (pH adjusted to 7·23 with NaOH). After the heart had been weighed, the aorta was cannulated and the heart was flushed with 3 ml of solution 1 with heparin added (20 U ml-1) using a syringe. The cannulated heart was then perfused retrogradely using a Langendorff system with 10-15 ml of oxygenated solution 1 (37°C) at a rate of approximately 1 ml min-1 followed by perfusion for 5 min with solution 1 (pH 7·23) to which was added albumin (1·3 mg ml-1; Miles Pharmaceuticals), collagenase (Type II, 0·42 mg ml-1; Gibco) and protease (Type XIV, 0·08 mg ml-1; Sigma). The heart was then cut down from the cannula, the atria removed and the ventricles chopped and placed in 5 ml of the enzyme-containing solution 1 in a small flask, which was shaken in a water bath at 37°C for 10-20 min. Every 5 min, the supernatant was filtered through a mesh and the cells centrifuged for 1 min at 1000 r.p.m. Following removal of the supernatant, the cells were resuspended in solution 2 (solution 1 modified by the addition of 10 mg ml-1 albumin, pH 7·4 with NaOH) for a short time and then spun again and resuspended in Tyrode solution containing (mM): NaCl, 132; KCl, 4·8; MgCl2, 1·2; CaCl2, 0·05; glucose, 5; and Hepes, 10, and stored at room temperature (20-23°C).
Solutions
Action potentials were recorded in Tyrode solution containing (mM): NaCl, 132; KCl, 4·8; MgCl2, 1·2; CaCl2, 1; glucose, 5; and Hepes, 10. For the measurement of whole-cell K+ currents the external solution contained (mM): KCl, 5; N-methyl-glucamine, 125; MgCl2, 1; CaCl2, 1; Hepes, 10; and glucose, 5 (pH 7·4 with KCl). In experiments to study K+ currents, nisoldipine (1 µM) was added to the extracellular solution to block the L-type Ca2+ current. The internal solution for recording both action potentials and whole-cell K+ currents contained (mM): potassium aspartate, 110; CaCl2, 1; Hepes, 10; EGTA, 11; MgCl2, 1; and K2ATP, 5 (pH 7·3 with KOH). Whole-cell L-type Ca2+ channel currents (ICa) were recorded using external solution containing (mM): CsCl, 5; Hepes, 10; N-methyl-glucamine, 125; glucose, 5; and MgCl2, 1. BaCl2 (1 mM) was added to this solution as a charge carrier. The internal solution contained (mM): aspartic acid, 50; K2ATP, 5; CsCl, 60; EGTA, 11; Hepes, 10; and CaCl2, 1 (pH 7·2 with CsOH). Stock concentrations of 4-aminopyridine (4-AP) and TEA-Cl (Sigma) were prepared in water, and a stock of nisoldipine (Miles Pharmaceuticals) was dissolved in ethanol.
Electrophysiology
Action potential and whole-cell current recordings were made at room temperature on cells freshly isolated daily. An aliquot of cells was placed in a Petri dish in Tyrode solution, and membrane current was recorded using patch pipettes (Clay Adams glass) with resistances of 1-4 M
when filled with internal solution. The activation of transient outward currents (Ito) was studied using 0·5 or 1 s step depolarizations from a holding potential of -60 mV, and the steady-state inactivation of Ito was studied using a two-pulse protocol: from -60 mV Ito was activated by a 1 s depolarization to +60 mV, followed by a 10 ms step back to the holding potential and a 1 s pulse to different test potentials in the range of -60 to +60 mV (10 mV increments). L-type Ca2+ channel currents were activated by 20 or 40 ms step depolarizations to a series of potentials from a -40 mV holding potential. Cell capacitance was estimated by integration of the capacity transient elicited by a 10 mV hyperpolarizing step from a holding potential of -40 mV. Series resistance was uncompensated and currents were low-pass filtered at 2 kHz.
Data analysis
Data were collected, stored and analysed on IBM-compatible computers interfaced to an Axopatch 200A amplifier (Axon Instruments) or a Yale mark IV amplifier (constructed in this laboratory) driven by pCLAMP software (Axon Instruments). Graphical and statistical data analysis were carried out using Origin software (Microcal, Northampton, MA, USA). Data from WT and transgenic mice are expressed as means ± S.E.M. (of n cells) and were compared using Student's t test (unpaired data), with a P value of < 0·05 taken to indicate statistical significance. Time constants were fitted to the inactivation of Ito using pCLAMP software (Chebyshev method) with the following equations for one or two exponential functions:
y(t) = Aexp(-t/
) + c,
y(t) = A1exp(-t/-
1) + A2exp(-t/-
2) + c,
where A is amplitude (pA), t is time (ms),
is time constant (ms) and c is steady state amplitude (pA).
Membrane preparation
For
-adrenergic receptor (
-AR) and adenylyl cyclase assays, tissue samples were taken from the left ventricular apex, in order to avoid the possible contamination of the sample with ectopic cell populations as described by Hassankhani et al. (1995) who found that such cells were almost exclusively confined to the atrium of the transgenic mouse heart. Ventricular myocardium (0·1 g) was trimmed, minced and homogenized in an ice-cold buffer containing 50 mM Tris-HCl, 120 mM NaCl and 5 mM KCl (pH 7·4). The homogenate was centrifuged at 500 g for 15 min at 4°C. The supernatant was filtered through gauze, collected and centrifuged at 40 000 g for 15 min at 4°C. The pellet was resuspended in the buffer and centrifuged again. The resultant pellet was filtered through a nylon membrane, aliquotted and stored at -70°C for future assays. For the following assays, the pellet was resuspended in a Tris buffer. The protein content was determined using BCA protein assay reagent (Pierce, Rockford, IL, USA) with bovine serum albumin as a standard.
Myocardial
-adrenergic receptor assay
Myocardial adrenergic receptor (AR) density was measured by specific binding of [125I]iodocyanopindolol ([125I]ICYP; specific activity, 2200 Ci mmol-1; New England Nuclear, Boston, MA, USA). Approximately 20 µg membrane protein was suspended in 0·2 ml of Tris-HCl buffer (pH 7·4) containing 120 mM NaCl and 5 mM KCl. Eight concentrations of [125I]ICYP (10-150 pM) were utilized. Non-specific binding was determined by parallel incubation of samples containing 10 µM propranolol. Incubations were performed in triplicate at 37°C for 60 min, in a final volume of 0·25 ml. The reaction was terminated by addition of ice-cold Tris-HCl buffer. The membranes were rapidly washed 3 times and filtered through Whatman GF/B filters (Whatman Chemical Separation, Clifton, NJ, USA) on a Brandel cell harvester (Biomedical Research and Development Laboratories, Inc., Gaithersburg, MD, USA). The filters were dried, punched out, and placed in scintillation vials. The samples were counted utilizing a Packard liquid scintillation counter (Packard Instrument Co, Inc., Downer's Grove, IL, USA). The difference between binding in the absence and presence of propranolol was taken as specific binding. The maximum number of receptor binding sites (Bmax) and the dissociation constant (KD) were calculated by Scatchard analysis of the binding data using the EBDA computer software program (Elsevier Science Publisher, Cambridge, UK) developed by McPherson (1985).
Myocardial
-adrenergic receptor subtypes assay
Myocardial
1- and
2-adrenergic receptor (AR) subtypes were identified by analysis of displacement curves utilizing the highly
1-AR-selective antagonist CGP 20712A (Dooley et al. 1986; Ciba-Geigy Pharmaceuticals, Basel, Switzerland). Membrane tissue (20 µg) was incubated in a 50 mM Tris buffer (pH 7·4) containing 120 mM NaCl, 5 mM KCl, 50 pM [125I]ICYP, and fourteen different concentrations of CGP 20712A, ranging from 1 pM to 0·1 mM. Incubations were performed in triplicate at 37°C for 60 min. The reaction was terminated by addition of ice-cold Tris buffer, and the samples were processed in the same fashion as for total AR measurement. Non-specific binding was determined by parallel incubation of samples containing 10 µM propranolol. The displacement curves were analysed for
1- and
2-AR density, fraction and respective dissociation constants (KD1 and KD2) with the GraphPad Prism Program (GraphPad Software, Inc., San Diego, CA, USA).
Adenylyl cyclase activity assay
Adenylyl cyclase activity was assayed in WT and NGF myocardium in the presence and absence of agonists. Three different agonists ((-)-isoprenaline, Gpp(NH)p (guanylylimidodiphosphate) and forskolin) were used to stimulate the
-AR-coupled adenylyl cyclase system: isoprenaline acts on the
-ARs to activate adenylyl cyclase; Gpp(NH)p, a GTP analogue, acts on
-AR-coupled guanine nucleotide-binding regulatory proteins (G-proteins), which transduce signals from
-AR to adenylyl cyclase; and forskolin increases the production of cAMP by acting on adenylyl cyclase or through the interaction between the G-protein and adenylyl cyclase. Adenylyl cyclase activity was assayed (Fan et al. 1987) with a mixture containing 50 mM Tris-HCl (pH 7·4), 0·4 mM EGTA, 0·5 mM 2-isobutyl-1-methylxanthine, 2 mM MgCl2, 5 mM phosphocreatine, 15 U creatine phosphokinase and approximately 50 µg membrane protein, in a final volume of 0·45 ml at 37°C for 5 min in the presence and absence of stimulator. The solvent for stimulators was distilled and deionized water, except for forskolin, which required 50 % DMSO to dissolve completely. Concentrations of stimulators required to elicit maximal production of cAMP were determined in pilot studies. They were as follows: isoprenaline, 0·1 mM with 0·1 mM GTP; Gpp(NH)p, 0·1 mM; forskolin, 0·1 mM. The reaction was started by adding 50 µl ATP to give a final concentration of 1 mM, and was terminated 10 min later by immersing the assay tube in a boiling water bath for 3 min. The samples were centrifuged at 1000 g at 4°C for 6 min, and the supernatant collected for measuring cAMP levels by the competitive protein-binding technique using a cAMP assay system (Amersham Life Science, Little Chalfont, Buckinghamshire, UK). All procedures were performed in duplicate.
 |
RESULTS |
Heart weight and heart weight/body weight ratio were significantly increased in NGF transgenic mice compared with WT mice (Table 1) but there was no difference in body weight. At the cellular level, the surface area of the myocytes was estimated by measuring the cell capacitance and found to be larger in cells isolated from the hearts of NGF transgenic mice, consistent with hypertrophy of the heart. In WT cells the mean cell capacitance was 233 ± 7 pF (n = 124) and in NGF cells, 260 ± 9·7 pF (n = 76; P < 0·05); the NGF myocytes were, therefore, 12 % larger than the WT myocytes.
Table 1. Comparison of body and heart weight in wild-type and NGF transgenic mice
| Body weight (g) | Heart weight (g) | HW/BW ratio (× 100) | n |
| Wild-type | 26·4 ± 0·63 | 0·21 ± 0·01 | 0·81 ± 0·02 | 18 |
| NGF transgenic | 24·81 ± 0·98 | 0·32 ± 0·02 * | 1·28 ± 0·05 * | 16 |
HW/BW ratio, heart weight/body weight ratio. Values are means ± S.E.M. * P < 0·0001 by Student's t test.
Altered electrophysiological properties in transgenic cardiomyocytes
Action potentials, stimulated at a frequency of 1 Hz, recorded from cells isolated from the hearts of WT mice displayed a very rapid repolarization typical of cells with a prominent transient outward current (Powell et al. 1980; Fiset et al. 1997), whereas those recorded from cells isolated from the hearts of NGF mice showed a much slower repolarization and, consequently, a longer action potential duration. Typical action potentials are shown in Fig. 1, and the mean data illustrate that the action potential duration at 50 and 90 % repolarization (APD50 and APD90) was significantly prolonged in NGF compared with WT cells. In WT cells the mean APD50 was 4·69 ± 0·49 ms (n = 9) compared with 9·42 ± 1·55 ms (P < 0·01; n = 8) in NGF cells, a prolongation of 101 %, and the APD90 in WT cells was 20·77 ± 5·11 ms (n = 9) compared with 50·34 ± 10·54 ms in NGF cells (P < 0·05; n = 8), a prolongation of 142 %. The resting membrane potentials of WT and NGF cells were not significantly different (WT, -67·4 ± 3 mV, n = 9; NGF, -75·2 ± 3 mV, n = 8). The prolonged action potential in the NGF cardiomyoctyes might result from an alteration in the properties of a variety of ionic currents including outward K+ currents and inward Ca2+ currents, and these possibilities were investigated.
|
 |
View larger version
[in this window]
[in a new window] |
|
|
Figure 1. Comparison of action potentials and mean action potential duration data from WT and NGF myocytes
Action potentials (1 Hz stimulation) recorded from WT (A) and NGF (B) myocytes. Arrows indicate 0 mV. C, mean APD50 and APD90 data in WT ( , n = 9) and NGF ( , n = 8) myocytes. * P < 0·05, ** P < 0·01.
|
A prominent transient outward K+ current (Ito) was the dominant outward current recorded in both WT and NGF myocytes, as has been reported previously in mice (Benndorf & Nilius, 1988). In other species, such as dog, the transient outward K+ currents consist of two components: a Ca2+-independent 4-AP-sensitive current and a Ca2+-dependent current. We focused on the former, which has previously been shown to be decreased in a variety of models of heart failure (Benitah et al. 1993; Beuckelmann et al. 1993; Cerbai et al. 1994; Tomita et al. 1994; Potreau et al. 1995; Kääb et al. 1996), and suppressed the Ca2+-dependent current by the inclusion of 11 mM EGTA in the patch pipette. Experiments described below demonstrate that all the Ito recorded under these conditions was sensitive to block by 4-AP, consistent with the presence of only the Ca2+-independent Ito.
Typical records of Ito recorded from a WT and a NGF myocyte are shown in Fig. 2A and B, respectively, and demonstrate the rapid inactivation of Ito superimposed on a steady-state current. Ito recorded from NGF cells was markedly reduced in amplitude compared with Ito in WT cells. The current was measured as the difference between the peak and end-pulse current and normalized to cell capacitance. Figure 2C shows the current-voltage relation of Ito in WT and NGF cells and clearly shows the reduction in the current density in NGF myocytes compared with WT myocytes: the amplitude of Ito activated by a step depolarization to +60 mV was 20·3 ± 4·23 pA pF-1 in WT cells (n = 28) compared with 9·76 ± 1·02 pA pF-1 in NGF cells (n = 23; P < 0·05). The steady-state current, estimated by measuring the current at the end of the pulse relative to zero current and normalized to cell capacitance, was smaller in NGF cells, but this difference was not statistically significant (WT, 16·6 ± 3·42 pA pF-1, n = 28; NGF, 10·2 ± 0·72 pA pF-1, n = 23; P > 0·05).
|
 |
View larger version
[in this window]
[in a new window] |
|
|
Figure 2. A comparison of the properties of Ito in WT and NGF myocytes
Typical Ito recorded from WT (A) and NGF (B) myocytes from a holding potential of -60 mV, activated by 500 ms step depolarizations to potentials between -40 and +60 mV. C, mean transient outward current density in WT ( ) and NGF myocytes ( ). * P < 0·05. D, voltage-dependent activation (WT, , n = 28; NGF, , n = 23) and steady-state inactivation (WT, , n = 9; NGF, , n = 14) of Ito. Dotted and continuous lines are fits to the NGF and WT data, respectively.
|
The reduction in the amplitude of Ito in NGF cells might reflect a change in the voltage range over which Ito activates or inactivates. Therefore, the voltage dependence of activation and the steady-state inactivation of Ito were investigated. Examination of the activation of Ito at different voltages fitted with a Boltzmann function (Fig. 2D) revealed no difference between the voltage dependence of activation of Ito in WT and NGF myocytes. The V½ was 18·0 ± 1·59 mV in WT cells (n = 28) and 20·1 ± 1·59 mV in NGF cells (n = 23), and the slope was 16·7 ± 0·4 mV in WT cells and 15·8 ± 0·81 mV in NGF cells (Fig. 2D). Similarly, the steady-state inactivation of Ito in WT and NGF cells fitted with a Boltzmann function was not significantly different; the V½ of inactivation for WT cells was -27·9 ± 2·7 mV (n = 9) compared with -25·6 ± 2 mV (n = 14) for NGF cells, and the slope was 8·3 ± 0·6 mV for WT cells and 9·6 ± 0·3 mV in NGF cells (Fig. 2D).
The rate of inactivation of Ito was quantified by fitting curves to the current inactivating during a step depolarization to +60 mV of 1 s duration. The inactivation of Ito recorded from all WT myocytes (n = 16) could consistently be fitted by two exponential functions with a fast and a slow time constant. In twenty out of twenty-four cells, the inactivation of Ito from NGF myocytes was also best fitted by fast and slow time constants. Figure 3A and B shows two typical records of Ito from a WT and a NGF myocyte activated by a 500 ms step depolarization to +60 mV and fitted with an exponential function (dotted line). Mean data for those cells fitted with a double-exponential function showed no significant difference between WT and NGF fast and slow time constants (Fig. 3C). The amplitude of the fast time constant (amplitude 1) was significantly smaller in NGF cells compared with WT (Fig. 3D). In WT cells, amplitude 1 was 8·6 ± 1·8 pA pF-1 (n = 16) and in NGF mice, amplitude 1 was 4·5 ± 0·6 pA pF (n = 20, P < 0·05). There was no difference in the amplitude of the slow time constant (amplitude 2) in NGF and WT cells (WT cells, 7·2 ± 0·9; NGF cells, 6·0 ± 0·8; P > 0·05). In four of the NGF cells, Ito was fitted by only a single exponential with a relatively slow time constant of 115·2 ± 9 ms and an amplitude of 11·9 ± 3 pA pF-1 (n = 4; data not shown).
The difference in the cardiac Ito in WT and NGF heart described above might result from a change in the expression of the type of channel or channel combination that forms Ito in the mice overexpressing NGF. A great many K+ channels have been cloned from the heart that might contribute to the total cardiac Ito, and they have different sensitivities to block by agents such as TEA and 4-AP. Therefore, the pharmacology of the adult mouse Ito was compared in WT and NGF myocytes. Figure 4 shows records of Ito recorded from a WT and a NGF myocyte before (control) and after exposure to 5 mM TEA. In both the WT (upper panel) and NGF (lower panel) myocytes, TEA had no effect on Ito, and this result was observed in an additional four WT and four NGF myocytes. Figure 5 shows the effect of 5 mM 4-AP on Ito recorded from WT and NGF myocytes, and in this case the currents from both cells were completely blocked. Therefore, there was no difference between the sensitivity of Ito in WT and NGF cells to TEA and 4-AP. 4-AP will also block another K+ current, the sustained or ultra-rapid outward K+ current IK(ur) (Wang et al. 1993). To study this current in more detail, we used a lower concentration of 4-AP (50 µM), which selectively blocks IK(ur) (Wang et al. 1993). We found that the current sensitive to 50 µM 4-AP in WT and NGF myocytes was significantly smaller in amplitude in NGF myocytes than in WT myocytes following a depolarizing step to +60 mV (WT current, 5·62 ± 0·79 pA pF-1, n = 11; NGF current, 2·75 ± 0·75 pA pF-1, n = 6; P < 0·05; Fig. 6A). Typical currents recorded from a WT and a NGF cell are shown in Fig. 6B for control (a), after exposure to 50 µM 4-AP (b) and the 4-AP-sensitive current, IK(ur) (c).
|
 |
View larger version
[in this window]
[in a new window] |
|
|
Figure 4. Comparison of the effect of 5 mM TEA on Ito in WT and NGF myocytes
Typical records of Ito activated by 500 ms step depolarizations from -60 to +60 mV from WT (upper traces) and NGF (lower traces) myocytes before (Control) and after exposure to TEA. Arrows indicate zero current level.
|
|
 |
View larger version
[in this window]
[in a new window] |
|
|
Figure 5. Comparison of the effect of 5 mM 4-AP on Ito in WT and NGF myocytes
Typical records of Ito activated by 500 ms step depolarizations from -60 to +60 mV from WT (upper traces) and NGF (lower traces) myocytes, before (Control) and after exposure to 4-AP. Arrows indicate zero current level.
|
|
 |
View larger version
[in this window]
[in a new window] |
|
|
Figure 6. Comparison of IK(ur) (the current sensitive to 50 µM 4-AP) in WT and NGF myocytes
A, mean current sensitive to 50 µM 4-AP in WT ( , n = 11) and NGF ( , n = 6) myocytes. * P < 0·05. B, typical records of Ito from WT and NGF myocytes for control (a), in the presence of 4-AP (b), and the 4-AP-sensitive current obtained by subtraction (c). Currents were activated by 500 ms step depolarizations from a holding potential of -60 mV.
|
The prolongation of APD observed in the NGF myocytes might also be due to a reduction in inward Ca2+ channel current, ICa. Therefore, the amplitude of the ICa in WT and NGF myocytes was compared and the current-voltage relationship determined (Fig. 7). The amplitude of peak ICa was not different in WT and NGF cells; in WT cells, peak ICa was 5·91 ± 0·8 pA pF-1 (n = 17), and in NGF myocytes, 5·96 ± 1 pA pF-1 (n = 21). There was also no significant difference in the characteristics of the current-voltage relationship of ICa in WT and NGF myocytes.
|
 |
View larger version
[in this window]
[in a new window] |
|
|
Figure 7. Comparison of the voltage-dependent activation of ICa in WT and NGF myocytes
Mean voltage-dependent activation of the L-type Ca2+ channel current in WT and NGF myocytes. Currents were activated by 40 ms step depolarizations from a holding potential of -40 mV.
|
To test whether the observed reductions in Ito and IK(ur) in the NGF myocytes could account for the prolongation of APD, the change in APD in a WT cell was measured while Ito was partially blocked, such that it was of a similar amplitude as Ito recorded in the NGF cells. This was achieved by applying 1 mM 4-AP, which at this concentration also blocked IK(ur). As shown in Fig. 8A, the action potential recorded from a WT cell in normal Tyrode solution was more than doubled in duration after exposure to 1 mM 4-AP. In this cell, APD90 was increased by 157 %, a similar increase to that observed in cells isolated from the hearts of NGF mice. The shape of the action potential in the presence of 1 mM 4-AP was similar, although not identical, to the action potentials recorded from cells from the hearts of the NGF mice (see Fig. 1). In this experiment the 4-AP was washed out, allowing the action potential to return to almost the same duration as in control, and the cell was voltage clamped to a -60 mV holding potential. Ito currents were then recorded and 4-AP was applied again. 4-AP (1 mM) reduced Ito current at +60 mV by 61 % (Fig. 8B), comparable to the difference in the amplitude of Ito in the WT and NGF cells (see Fig. 2C).
|
 |
View larger version
[in this window]
[in a new window] |
|
|
Figure 8. Effect of 1 mM 4-AP on APD and Ito in a WT myocyte
A, action potentials recorded from a single WT myocyte in control, in the presence of 1 mM 4-AP and after washout of 4-AP. Action potentials were stimulated at 1 Hz. B, Ito recorded from the same cell after washout of 4-AP (a) and after re-exposure to 1 mM 4-AP (b).
|
Changes in
-adrenergic responses and
-AR density
Since the overexpression of NGF increases the sympathetic innervation of the heart and raises plasma catecholamine levels, it was of interest to study the response of the
-adrenergic signalling cascade. Therefore, since ICa is known to be regulated by this system, we studied the effect of
-AR stimulation by isoprenaline on peak ICa. Trains of pulses were applied to the potential at which peak ICa was activated in the absence and presence of 1 µM isoprenaline. We found that the response to isoprenaline was smaller in cells isolated from the NGF mice; after isoprenaline, ICa was increased in WT cells by 75·1 ± 11·5 % (n = 8) while in NGF cells, the increase with isoprenaline was significantly less at 44·4 ± 7·7 % (n = 8, P < 0·05; Fig. 9).
To investigate the basis for differences in
-AR agonist responses between NGF and WT cardiomyocytes, the density of
-ARs was measured. With ICYP, a selective ligand for myocardial
-ARs, binding was monophasic and revealed that total
-AR density (Bmax) was increased by 55 % in NGF tissue compared with WT, whilst the dissociation constants for total
-ARs did not differ between the WT and NGF mice (Table 2). Further analysis of
-AR subtypes was carried out using the highly selective
1-AR antagonist CGP 20712A and showed that the increase in
-AR density detected in NGF tissue was due entirely to an increase in
2-ARs in NGF tissue compared with WT tissue, with no change in the level of
1-ARs. The dissociation constants for the
-AR subtypes did not differ between the WT and NGF mice. These data are summarized in Table 2.
|
 |
View larger version
[in this window]
[in a new window] |
|
|
Figure 9. Effect of isoprenaline on peak ICa in WT and NGF myocytes
Trains of pulses (40 ms duration) to activate peak ICa were applied at 5 s intervals from a holding potential of -40 mV and peak current was measured. Cells from WT ( , n = 8) and NGF ( , n = 8) hearts were exposed to 1 µM isoprenaline and the percentage increase in peak current is shown. * P < 0·05.
|
Table 2. Myocardial
-AR density and subtypes in wild-type and NGF transgenic mice
| -AR density | Dissociation constants |
| Total (fmol (mg protein)-1) | 1-AR subtype (fmol (mg protein)-1) | 2-AR subtype (fmol (mg protein)-1) | KD (pM) | KD1 (nM) | KD2 (µM) |
| Wild-type | 35 ± 5 | 23 ± 3 | 12 ± 2 | 51 ± 9 | 10 ± 3 | 3·5 ± 1·2 |
| NGF transgenic | 55 ± 5 * | 27 ± 3 | 28 ± 3 ** | 59 ± 12 | 8 ± 3 | 3·8 ± 1·2 |
Values are means ± S.E.M., n = 9-11 in each group. * P < 0·05, ** P < 0·001 compared with wild-type by Student's t test. KD, dissociation constant for total
-AR population; KD1 and KD2, dissociation constants for
1- and
2-ARs, respectively.
Table 3. Basal and stimulated adenylyl cyclase activity in wild-type and NGF transgenic mice assayed by measuring cAMP levels
| | Stimulated activity | |
| Basal activity (pmol (mg protein)-1 min-1) | Isoprenaline ( pmol (mg protein)-1 min-1) | Gpp(NH)p ( pmol (mg protein)-1 min-1) | Forskolin ( pmol (mg protein)-1 min-1) | n |
| Wild-type | 2·1 ± 0·2 | 4·6 ± 0·8 | 13·2 ± 0·9 | 71·9 ± 5·3 | 11 |
| NGF transgenic | 2·7 ± 0·3 | 1·6 ± 0·2 * | 14·3 ± 1·5 | 61·2 ± 5·5 | 11 |
Values are means ± S.E.M. * P < 0·01 by Student's t test. Basal adenylyl cyclase activity was obtained in the presence of GTP. Stimulated adenylyl cylcase levels were the net increases above the basal levels under each assay condition.
Since the response of the Ca2+ channel current to isoprenaline, a non-selective
-AR agonist, was depressed in NGF cells, but the density of
2-ARs was increased, it was thought possible that the chronic increase in noradrenaline levels in the NGF myocardium might have uncoupled intracellular signalling pathways. To address this issue, the responses of the
-AR-coupled adenylyl cyclase system to isoprenaline, Gpp(NH)p and forskolin were studied by measuring cAMP production. In NGF tissue, isoprenaline elicited a significantly smaller response than in tissue from WT mice (Table 3). This diminished response was not due to reduced adenylyl cyclase activity as the responses of NGF tissue to Gpp(NH)p and forskolin were not signicantly different in NGF tissue compared with WT (Table 3).
 |
DISCUSSION |
Overexpression of NGF in the heart results in chronic heart failure characterized by cardiac hypertrophy secondary to an elevation of catecholamines caused by sympathetic hyperinnervation of the heart (Hassankhani et al. 1995). The elevated catecholamine levels are thought to be confined exclusively to the heart, and therefore this transgenic mouse provides a novel model in which to study the pathological influence of the increased sympathetic activity on the heart. Cardiac hypertrophy, occurring in many common cardiovascular diseases or induced in experimental models by chronic pressure or volume overload, is generally characterized by prolonged APD (see, for example, Aronson, 1980; Scamps et al. 1985; Kleiman & Houser, 1988; Nordin et al. 1989; Bouron et al. 1992; Ryder et al. 1993; Ten Eick & Basset, 1997). Accordingly, in this transgenic mouse with cardiac hypertrophy, the action potential was more than doubled in duration compared with WT mice, with no change in the resting membrane potential. Alterations in the duration of the action potential may predispose the heart cells to dispersion of repolarization, leading to re-entrant arrhythmias (Di Diego & Antzelevitch, 1994). In particular, prolonged action potentials favour the development of after-depolarizations, which in turn can induce triggered arrhythmias, and therefore these changes are potentially pathological.
The significant decrease in the current density of Ito and IK(ur) in cells isolated from the NGF mouse observed in this study is likely to have contributed to the prolonged APD. A great many K+ channels have been described in the heart (Barry & Nerbonne, 1996) and Ito and IK(ur) are two K+ currents which play a particularly important role during the action potential. They contribute to shaping the early phase of the cardiac action potential and the refractoriness of myocardial tissue (Wang et al. 1993; Campbell et al. 1997). In the mouse heart, block of the K+ current sensitive to 50 µM 4-AP (namely IK(ur)) caused significant changes in APD and, as a result, in force of contraction (Fiset et al. 1997). A reduction in Ito has been reported before in a variety of models of cardiac failure including pressure overload-induced cardiac hypertrophy (Benitah et al. 1993; Tomita et al. 1994; Potreau et al. 1995), hypertrophy secondary to hypertension (Cerbai et al. 1994), and pacing-induced heart failure (Kääb et al. 1996), and in cells isolated from patients with terminal heart failure (Beuckelmann et al. 1993), and is thought to contribute to long-QT and possibly to the generation of arrhythmias in heart failure.
The molecular nature of Ito and IK(ur) in the mouse is not completely clear, but the Kv1.5 channel is thought to underlie IK(ur) (Fiset et al. 1997) and has been cloned from mouse (Attali et al. 1993). Channels from the Kv4 family are thought most likely to underlie cardiac Ito in canine and rat, and both Kv4.2 and Kv4.3 mRNAs have been found in the mouse ventricle and atrium (Fiset et al. 1998). These channels share a similar sensitivity to 4-AP and insensitivity to TEA as Ito observed in the mouse heart (Dixon et al. 1996; Yeola & Snyders, 1997). Therefore it seems likely that genes from the Kv4 family also code for Ito in the mouse heart.
The mechanism by which the current density of Ito is reduced in the failing heart is not known. One hypothesis is that the current density decreases in hypertrophy because of an increase in the size of the cell membrane which is not accompanied by a corresponding increase in the expression of the K+ channels. However, the increase in capacitance in the NGF cells was only 12 %, whereas the density of Ito and IK(ur) in NGF myocytes was only 40-50 % of those currents measured in WT cells. Given these data, it seems more likely that there was a downregulation in the number of channels or of a channel subunit expressed during the development of heart failure in the NGF mouse. It is possible that gene expression may be altered during the development and progression of heart failure. Indeed, the expression of K+ channel genes has previously been shown to change during heart failure: a downregulation of Kv4.2 and Kv4.3 was reported in the hearts of rats with renovascular hypertension which caused an increase in afterload on the heart (Takimoto et al. 1997), and in a rat model of heart failure in which cardiac hypertrophy was induced by myocardial infarction, the levels of Kv2.1 and Kv4.2 mRNA and gene product were reduced whereas no reduction was seen in the mRNA or protein levels of Kv1.5, the channel that has been shown to underlie IK(ur) (Feng et al. 1997; Fiset et al. 1998). However, in two other studies, one on hypertrophied rat ventricle and the second on human atrial cells from patients with chronic atrial fibrillation, significant reductions in Kv1.5 mRNA levels were found (Matsubara et al. 1993; Van Wagoner et al. 1997). Therefore, it seems likely that K+ channel expression can be altered in hypertrophy despite some variations between the different models studied.
While these studies indicate that K+ channel proteins are downregulated in hypertrophy, it is also possible that in the NGF mouse heart there was a change in the assembly of channel subunits or regulatory subunits, such as
-subunits, which modify channel properties. However, since we did not see any change in the electrophysiological or pharmacological properties of the K+ currents which were reduced in density in the NGF mouse heart, there is little evidence to suggest changes in such proteins occurred in this model.
Another possible explanation for the observed decrease in Ito in the NGF mouse heart is an increase in
1-adrenergic stimulation as a result of the elevated catecholamine levels in the hearts of the NGF mice. Unlike
-ARs (see later), it is thought that the absolute number of
1-adrenergic receptors remains the same in heart failure (Bristow et al. 1988).
1-Adrenergic agonist-induced inhibition of Ito has been observed in rabbit atrial (Fedida et al. 1990) and rat ventricular cells (for example, see Ertl et al. 1991) through activation of protein kinase C, and although some of these reductions in Ito are relatively small they may at least contribute to the observed reduction in Ito in NGF cells.
The prolongation of APD in the NGF mice was probably not due to an increase in Ca2+ current. No difference in the Ca2+ current density in WT and NGF myocytes was observed. Conflicting results have previously been reported concerning changes in Ca2+ current density and characteristics in various models of hypertrophy. The current density was reported to be unchanged (Scamps et al. 1985; Kleiman & Houser, 1988; Cerbai et al. 1994), increased (Keung, 1989; Ryder et al. 1993) and decreased (Nuss & Houser, 1991; Rossner, 1991; Bouron et al. 1992) in different models of heart failure. It seems likely that variations between species and the degree of heart failure might influence the changes in the Ca2+ current in these different models (see Lee et al. 1997).
The effect of 1 mM 4-AP on the action potential duration and the outward K+ currents provides further support for the hypothesis that the reduction in Ito and IK(ur) in cells from NGF hearts was sufficient to account for the action potential prolongation in the NGF mice. This concentration of 4-AP caused a 61 % reduction in the Ito current and reduced the end-pulse current (reflecting block of IK(ur)) by more than half, similar to the amplitude of Ito and IK(ur) observed in myocytes isolated from the NGF mice. Any differences between the shape of the action potentials recorded in the presence of 1 mM 4-AP and of those recorded from cells isolated from the hearts of NGF mice may reflect slight differences in the amount of each type of K+ current either blocked by 4-AP or reduced following overexpression of NGF. However, in the presence of 4-AP, the action potential was more than doubled in duration. This was an increase similar to that recorded from the NGF mouse cells and therefore consistent with the prolonged action potential in cells from NGF mice resulting from a decrease in these currents.
Both decreases (Bristow et al. 1988) and increases (Vatner et al. 1985) in
-AR density in heart failure have been reported previously, and in this study we found an increase in
-AR density in NGF transgenic mouse cardiac tissue. Further analysis of
-AR subtypes revealed the novel finding that only
2-ARs were increased in density. However, despite this increase, the response of ICa to isoprenaline was reduced in NGF myoyctes. This was not due to a decrease in receptor affinity as the dissociation constants were not changed. Instead, we found that isoprenaline-stimulated adenylyl cyclase activity was depressed in NGF compared with WT cardiac tissue, although there was no change in the response of adenylyl cyclase to Gpp(NH)p or forskolin, findings which are consistent with an uncoupling of the
-ARs from the adenylyl cyclase signalling pathway and which explain the diminished response of ICa to
-AR stimulation.
It is possible that the increase in
2-AR density occurred as a compensatory mechanism in response to the uncoupling of the receptors, and these changes occurred as a result of the exposure of the heart to the excess levels of catecholamines in the NGF mice. Thus the chronic catecholamine excess influences both receptor expression in the heart and the coupling to the G-protein-linked signal transduction pathways, pathophysiological processes observed previously in the failing human heart (Bristow et al. 1982).
In conclusion, the overexpression of NGF in the mouse heart results in a chronic catecholamine excess and heart failure characterized by a prolongation of the cardiac action potential. This change is due, at least in part, to a reduction in the density of two outward K+ currents, Ito and IK(ur), which are important in cardiac repolarization. In addition, there was a reduction in
-AR function; despite an increase in the density of
2-ARs in the NGF myocardium, the functional coupling of the receptors to the adenylyl cyclase signalling pathway was reduced such that the response of the ICa to isoprenaline was markedly diminished. These potentially pathological changes may be involved in the occurrence of ventricular arrhythmias in hypertrophied hearts, and this mouse provides a novel system in which to study such changes.
 |
REFERENCES |
| Aronson, R. S. (1980). Characteristics of action potentials of hypertrophied myocardium from rats with renal hypertension. Circulation Research 47, 443-454 |
[Medline] |
| Attali, B., Lesage, F., Ziliani, P., Guillemare, E., Honore, E. X., Waldmann, R., Hugnot, J. P., Mattei, M. G., Lazdunski, M. & Barhanin, J. (1993). Multiple mRNA isoforms encoding the mouse cardiac Kv1.5 delayed rectifier K+ channel. Journal of Biological Chemistry 268, 24283-24289 |
[Abstract] |
| Barry, D. M. & Nerbonne, J. M. (1996). Myocardial potassium channels: electrophysiological and molecular diversity. Annual Review of Physiology 58, 363-394 |
[Abstract] |
| Benitah, J. P., Gomez, A. M., Bailly, P., Da Ponte, J. P., Berson, G. X., Delgado, C. & Lorente, P. (1993). Heterogeneity of the early outward current in ventricular cells isolated from normal and hypertrophied rat hearts. The Journal of Physiology 469, 111-138 |
[Abstract] |
| Benndorf, K. & Nilius, B. (1988). Properties of an early outward current in single cells of the mouse ventricle. General Physiology and Biophysics 7, 449-466 |
[Medline] |
| Beuckelmann, D. J., Nabauer, M. & Erdmann, E. (1993). Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure. Circulation Research 73, 379-385 |
[Abstract] |
| Bouron, A., Potreau, D. & Raymond, G. (1992). The L-type calcium current in single hypertrophied cardiomyocytes isolated from the right ventricle of ferret heart. Cardiovascular Research 26, 662-670 |
[Medline] |
| Bristow, M. R., Ginsburg, R., Minobe, W., Cubicciotti, R. S. X., Sageman, W. S., Lurie, K., Billingham, M. E., Harrison, D. C. & Stinson, E. B. (1982). Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. New England Journal of Medicine 307, 205-211 |
[Abstract] |
| Bristow, M. R., Minobe, W., Rasmussen, R., Hershberger, R. E. X. & Hoffman, B. B. (1988). Alpha-1 adrenergic receptors in the nonfailing and failing human heart. Journal of Pharmacology and Experimental Therapeutics 247, 1039-1045 |
[Abstract] |
| Campbell, D., Rasmusson, R., Corner, M. & Strauss, H. (1997). The cardiac calcium-independent outward potassium current: kinetics, molecular properties and role in ventricular repolarization. In Cardiac Electrophysiology: From Cell to Bedside, 2nd edn, ed. Zipes, D. & Jaliffe, J., pp. 83-96. W. B. Saunders and Co., Philadelphia. |
|
| Cerbai, E., Barbieri, M., Li, Q. & Mugelli, A. (1994). Ionic basis of action potential prolongation of hypertrophied cardiac myocytes isolated from hypertensive rats of different ages. Cardiovascular Research 28, 1180-1187 |
[Medline] |
| Di Diego, J. M. & Antzelevitch, C. (1994). High [Ca2+]o-induced electrical heterogeneity and extra-systolic activity in isolated canine ventricular epicardium. Circulation 89, 1839-1850 |
[Abstract] |
| Dixon, J. E., Shi, W., Wang, H.-S., McDonald, C., Yu, H., Wymore, R. S., Cohen, I. S. & McKinnon, D. (1996). Role of the Kv4.3 K+ channel in ventricular muscle. A molecular correlate for the transient outward current. Circulation Research 79, 659-668 |
[Abstract/Full Text] |
Dooley, D. J., Bittinger, H. & Reymann, N. C. (1986). CGP 20712A: A useful tool for quantitating 1- and 2- adrenoceptors. European Journal of Pharmacology 130, 137-139 |
[Medline] |
| Ertl, R., Jahnel, U., Nawrath, H., Carmeliet, E. & Vereecke, J. (1991). Differential electrophysiologic and inotropic effects of phenylephrine in atrial and ventricular heart muscle preparations from rats. Naunyn-Schmiedeberg's Archives of Pharmacology 344, 574-581. |
[Medline] |
| Fan, T. H., Liang, C. S., Kawashima, S. & Banerjee, S. P. (1987). Alterations in cardiac beta-adrenoceptor responsiveness and adenylate cyclase system by congestive heart failure in dogs. European Journal of Pharmacology 140, 123-132 |
[Medline] |
| Fedida, D., Shimoni, Y. & Giles, W. R. (1990). Alpha-adrenergic modulation of the transient outward current in rabbit atrial myocytes. The Journal of Physiology 423, 257-277 |
[Abstract] |
| Feng, J., Wible, B., Li, G. R., Wang, Z. & Nattel, S. (1997). Antisense oligodeoxynucleotides directed against Kv1.5 mRNA specifically inhibit ultrarapid delayed rectifier K+ current in cultured adult human atrial myocytes. Circulation Research 80, 572-579 |
[Abstract/Full Text] |
| Fiset, C., Clark, R. B., Janzen, K. M., Winkfein, R. & Giles, W. R. (1998). Molecular identity of K+ currents in adult mouse atrium and ventricle. Biophysical Journal 74, A207. |
|
| Fiset, C., Clark, R. B., Larsen, T. S. & Giles, W. R. (1997). A rapidly activating sustained K+ current modulates repolarization and excitation-contraction coupling in adult mouse ventricle. The Journal of Physiology 504, 557-563 |
[Abstract] |
| Francis, G. S., Cohn, J. N., Johnson, G., Rector, T. S., Goldman, S. & Simon, A. (1993). Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA cooperative studies group. Circulation 87, VI 40-48 |
[Medline] |
| Hart, G. (1994). Cellular electrophysiology in cardiac hypertrophy and failure. Cardiovascular Research 28, 933-946 |
[Medline] |
| Hassankhani, A., Steinhelper, M. E., Soonpaa, M. H., Katz, E. B. X., Taylor, D. A., Andrade-Rozental, A., Factor, S. M., Steinberg, J. J., Field, L. J. X. & Federoff, H. J. (1995). Overexpression of NGF within the heart of transgenic mice causes hyperinnervation, cardiac enlargement, and hyperplasia of ectopic cells. Developmental Biology 169, 309-321. |
[Medline] |
| Kääb, S., Nuss, H. B., Chiamvimonvat, N., O'Rourke, B., Pak, P. H. X., Kass, D. A., Marban, E. & Tomaselli, G. F. (1996). Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circulation Research 78, 262-273 |
[Abstract/Full Text] |
| Keung, E. C. (1989). Calcium current is increased in isolated adult myocytes from hypertrophied rat myocardium. Circulation Research 64, 753-763 |
[Abstract] |
| Kleiman, R. B. & Houser, S. R. (1988). Calcium currents in normal and hypertrophied isolated feline ventricular myocytes. American Journal of Physiology 255, H1434-1442 |
[Medline] |
| Kottkamp, H., Budde, T., Lamp, B., Haverkamp, W., Borggrefe, M. X. & Breithardt, G. (1994). Clinical significance and management of ventricular arrhythmias in heart failure. European Heart Journal 15, suppl. D, 155-163. |
|
| Lee, J. K., Kodama, I., Honjo, H., Anno, I., Kamiua, K. & Toyama, J. (1997). State-dependent changes in membrane currents in rats with monocrotaline-induced right ventricular hypertrophy. American Journal of Physiology 272, H2833-2842 |
[Medline] |
| McPherson, G. A. (1985). Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC. Journal of Pharmacological Methods 14, 213-228 |
[Medline] |
| Matsubara, H., Suzuki, J. & Inada, M. (1993). Shaker-related potassium channel, Kv1.4, mRNA regulation in cultured rat heart myocytes and differential expression of Kv1.4 and Kv1.5 genes in myocardial development and hypertrophy. Journal of Clinical Investigation 92, 1659-1666 |
[Medline] |
| Nordin, C., Siri, F. & Aronson, R. S. (1989). Electrophysiologic characteristics of single myocytes isolated from hypertrophied guinea-pig hearts. Journal of Molecular and Cellular Cardiology 21, 729-739 |
[Medline] |
| Nuss, H. B. & Houser, S. R. (1991). Voltage dependence of contraction and calcium current in severely hypertrophied feline ventricular myocytes. Journal of Molecular and Cellular Cardiology 23, 717-726 |
[Medline] |
| Potreau, D., Gomez, J. P. & Fares, N. (1995). Depressed transient outward current in single hypertrophied cardiomyocytes isolated from the right ventricle of ferret heart. Cardiovascular Research 30, 440-448 |
[Medline] |
| Powell, T., Terrar, D. A. & Twist, V. W. (1980). Electrical properties of individual cells isolated from adult rat ventricular myocardium. The Journal of Physiology 302, 131-153 |
[Abstract] |
| Rossner, K. L. (1991). Calcium current in congestive heart failure of hamster cardiomyopathy. American Journal of Physiology 260, H1179-1186 |
[Medline] |
| Ryder, K. O., Bryant, S. M. & Hart, G. (1993). Membrane current changes in left ventricular myocytes isolated from guinea pigs after abdominal aortic coarctation. Cardiovascular Research 27, 1278-1287 |
[Medline] |
| Scamps, F., Mayoux, E., Charlemagne, D. & Vassort, G. (1985). Calcium current in single cells isolated from normal and hypertrophied rat heart. Effects of beta-adrenergic stimulation. Circulation Research 67, 199-208. |
[Abstract] |
| Schwartz, P. J., Vanoli, E., Zaza, A. & Zuanetti, G. (1985). The effect of antiarrhythmic drugs on life-threatening arrhythmias induced by the interaction between acute myocardial ischemia and sympathetic hyperactivity. American Heart Journal 109, 937-948 |
[Medline] |
| Takimoto, K., Li, D. Q., Hershman, K. M., Li, P., Jackson, E. K. & Levitan, E. S. (1997). Decreased expression of of Kv4.2 and novel Kv4.3 K+ channel subunit mRNAs in ventricles of renovascular hypertensive rats. Circulation Research 81, 533-539 |
[Abstract/Full Text] |
| Ten Eick, R. E. & Basset, A. L. (1997). Cardiac hypertrophy and altered cellular electrical activity of the myocardium: possible electrophysiological basis for myocardial contractility changes. In Physiology and Pathophysiology of the Heart, ed. Sperelakis, N., pp. 521-542. Martinus Nihoff, The Netherlands. |
|
| Tomita, F., Bassett, A. L., Myerburg, R. J. & Kimura, S. (1994). Diminished transient outward currents in rat hypertrophied ventricular myocytes. Circulation Research 75, 296-303 |
[Abstract] |
| Van Wagoner, D. R., Pond, A. L., McCarthy, P. M., Trimmer, J. S. & Nerbonne, J. M. (1997). Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circulation Research 80, 772-781 |
[Abstract/Full Text] |
Vatner, D. E., Vatner, S. F., Fujii, A. M. & Homey, C. J. (1985). Loss of high affinity cardiac -adrenergic receptors in dogs withheart failure. Journal of Clinical Investigation 76, 2259-2264 |
[Medline] |
| Wang, Z., Fermini, B. & Nattel, S. (1993). Sustained depolarization-induced outward current in human atrial myocytes. Evidence for a novel delayed rectifier K+ current similar to Kv1.5 cloned channel currents. Circulation Research 73, 1061-1076 |
[Abstract] |
| Yeola, S. W. & Snyders, D. J. (1997). Electrophysiological and pharmacological correspondence between Kv4.2 current and rat cardiac transient outward current. Cardiovascular Research 33, 540-547 |
[Medline] |
Corresponding author
R. S. Kass: College of Physicians and Surgeons of Columbia University, Department of Pharmacology, 630 West 168th Street, New York, NY 10032, USA.
Email: rsk20{at}colombia.edu
Authors' present addresses
B. M. Heath: University Department of Pharmacology, Oxford, OX1 3QT, UK.
Email: bronagh.heath{at}pharm.ox.ac.uk
H. J. Federoff, E. Dong * and S. Liang *: Departments of Neurology, Microbiology, Immunology and * Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
This article has been cited by other articles:

|
 |

|
 |
 
S. Baba, T. Heike, M. Yoshimoto, K. Umeda, H. Doi, T. Iwasa, X. Lin, S. Matsuoka, M. Komeda, and T. Nakahata
Flk1+ cardiac stem/progenitor cells derived from embryonic stem cells improve cardiac function in a dilated cardiomyopathy mouse model
Cardiovasc Res,
October 1, 2007;
76(1):
119 - 131.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kiriazis, X.-J. Du, X. Feng, E. Hotchkin, T. Marshall, S. Finch, X.-M. Gao, G. Lambert, J. K. Choate, and D. M. Kaye
Preserved left ventricular structure and function in mice with cardiac sympathetic hyperinnervation
Am J Physiol Heart Circ Physiol,
October 1, 2005;
289(4):
H1359 - H1365.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Brouillette, R. B. Clark, W. R. Giles, and C. Fiset
Functional properties of K+ currents in adult mouse ventricular myocytes
J. Physiol.,
September 15, 2004;
559(3):
777 - 798.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Canty Jr and J. A. Fallavollita
Sympathetic Nerves and Myocyte Necrosis: More Than Meets the Eye
Circ. Res.,
October 31, 2003;
93(9):
796 - 798.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Czarnecki, L. Dufy-Barbe, S. Huet, M.-F. Odessa, and L. Bresson-Bepoldin
Potassium channel expression level is dependent on the proliferation state in the GH3 pituitary cell line
Am J Physiol Cell Physiol,
April 1, 2003;
284(4):
C1054 - C1064.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Danik, C. Cabo, C. Chiello, S. Kang, A. L. Wit, and J. Coromilas
Correlation of repolarization of ventricular monophasic action potential with ECG in the murine heart
Am J Physiol Heart Circ Physiol,
July 1, 2002;
283(1):
H372 - H381.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Qin, N. K. Rounds, W. Mao, K. Kawai, and C.-s. Liang
Antioxidant vitamins prevent cardiomyocyte apoptosis produced by norepinephrine infusion in ferrets
Cardiovasc Res,
September 1, 2001;
51(4):
736 - 748.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-J. Du
Sympathoadrenergic mechanisms in functional regulation and development of cardiac hypertrophy and failure: findings from genetically engineered mice
Cardiovasc Res,
June 1, 2001;
50(3):
443 - 453.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Stener-Victorin, T. Lundeberg, U. Waldenström, L. Manni, L. Aloe, S. Gunnarsson, and P. O. Janson
Effects of Electro-Acupuncture on Nerve Growth Factor and Ovarian Morphology in Rats with Experimentally Induced Polycystic Ovaries
Biol Reprod,
November 1, 2000;
63(5):
1497 - 1503.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. P. Thomas, L. Bircher-Lehmann, S. A. Thomas, J. Zhuang, J. E. Saffitz, and A. G. Kleber
Synthetic Strands of Neonatal Mouse Cardiac Myocytes : Structural and Electrophysiological Properties
Circ. Res.,
September 15, 2000;
87(6):
467 - 473.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. H. DuBell, W. J. Lederer, and T. B. Rogers
K+ currents responsible for repolarization in mouse ventricle and their modulation by FK-506 and rapamycin
Am J Physiol Heart Circ Physiol,
March 1, 2000;
278(3):
H886 - H897.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-J. Du and A. M. Dart
Role of sympathoadrenergic mechanisms in arrhythmogenesis
Cardiovasc Res,
September 1, 1999;
43(4):
832 - 834.
[Full Text]
[PDF]
![]() |